发明名称 |
METHODS FOR TREATING CANCER USING A COMBINATION OF A TUMOR-DERIVED DENDRITIC CELL INHIBITORY FACTOR ANTAGONIST AND A TOLL-LIKE RECEPTOR AGONIST |
摘要 |
Dendritic cells (DC) play a critical role in antigen-specific immune responses. Materials and methods are provided for treating disease states, including cancer, by activating dendritic cells from the host which are rendered hypo-responsive to activation stimuli by the disease. In particular , methods are provided for treating cancer in a mammal comprising administerin g to said mammal an effective amount of a tumor-derived DC inhibitory factor antagonist in combination with an effective amount of a Toll-like receptor (TLR) agonist.
|
申请公布号 |
CA2468320(A1) |
申请公布日期 |
2003.06.05 |
申请号 |
CA20022468320 |
申请日期 |
2002.11.26 |
申请人 |
SCHERING CORPORATION |
发明人 |
VICARI, ALAIN P.;CAUX, CHRISTOPHE |
分类号 |
A61K31/7088;A61K39/395;A61K45/06;A61K47/48;C12N5/08;(IPC1-7):A61K39/395;A61K39/00;A61K38/19;A61K31/405;A61K31/708 |
主分类号 |
A61K31/7088 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|